Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy

Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy

BackgroundChimeric antigen receptor T cell infusion (CAR T) therapy has revolutionized the treatment of hematologic malignancies, but treatment-related toxicities are of concern. Understanding the timing and reasons for which patients present to the emergency department (ED) after CAR T therapy can...

Full description

Bibliographic Details
Main Authors: Demis N. Lipe, Aiham Qdaisat, Patrick Chaftari, Monica K. Wattana, Pavitra P. Krishnamani, Cielito Reyes-Gibby, Sai-Ching J. Yeung
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
chimeric antigen receptor T cells
emergency department
CAR T cells
utilization
Mortality
disposition
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1122329/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1122329/full

Similar Items